We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Tissue Preparation Solution Enables Increased Efficiency for Molecular Pathology Laboratories

By LabMedica International staff writers
Posted on 27 Nov 2013
A new tissue preparation system now enables automated extraction of high-quality nucleic acids from fresh frozen tissues as well as from formalin-fixed paraffin embedded (FFPE) tissues. More...


Siemens Healthcare Sector (Malvern, PA, USA) now offers its “Tissue Preparation Solution,” which includes a Tissue Preparation System and the Versant Tissue Preparation Reagents kit. Fresh frozen (FF) tissues are typically used for quick diagnosis of patients undergoing surgery, for research, or for tissue collection and storage. Formalin-fixed, paraffin embedded tissue clinical samples are routinely prepared from tissues obtained from surgeries and biopsies. FF tissue samples usually require separate workflows and specific kits not compatible with FFPE tissues, making the integration of these two processes a challenge for molecular pathology labs. Now, the consolidation of both tissue types on the Siemens Tissue Preparation Solution provides the only automated solution currently available for standardized isolation of nucleic acids from both FF and FFPE tissue samples such as those obtained for in vitro diagnosis and research.

Before the introduction of this Siemens solution, laboratories were limited to systems that were either manual or only automated for certain steps of the process. “When compared to other manual and semi-automated procedures, the Siemens method really sets a new standard in quality and workflow efficiency for routine molecular pathology laboratories,” commented Manfred Dietel, MD, Director of Institute of Pathology, University Hospital, Charité Berlin (Germany).

Using magnetic particle-based isolation and proprietary bead technology, this solution provides a more efficient and reproducible process for the isolation of high-quality nucleic acids from FFPE tissue. It features an automated process including the integration of deparaffinization; eliminates centrifugation steps associated with deparaffinization; enables coextraction of DNA and RNA from a single extraction process with a single set of reagents; provides a standardized lysis step for all samples; delivers highly reproducible results; and processes up to 48 samples in about 4 hours. Laboratory safety and environmental quality are also enhanced as hazardous organic solvents are eliminated with the deparaffinization process.

Related Links:

Siemens Healthcare



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.